Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal Motility
Open accessThe DOI matches its Crossref record; 159 of the 161 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide-1 (GLP-1) receptor agonists and the dual GLP-1- and glucose-dependent insulinotropic polypeptide receptor co-agonist tirzepatide (referred to here collectively as “GLP-1-based therapy”) are incretin-based therapies being used increasingly in the management of both type 2 diabetes and obesity. They are now recognized to have beneficial effects beyond improved glycemic control and weight loss, including cardiovascular and renal protection. GLP-1-based therapy also slows gastric emptying, which has benefits (lowering postprandial glucose), but also potential risks (eg, hypoglycemia in individuals on insulin or sulphonylurea therapy). Their effects on the gallbladder may also be beneficial, contributing to reducing postprandial triglycerides, but they also potentially increase the risk of biliary disease. In this review, we summarize the effects of GLP-1 and incretin-based therapeutics on gastric, biliary and small intestinal function. An improved understanding of these effects will optimize the use of these drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The capacity of GLP-1 RAs to decelerate gastric emptying to levels indicative of gastroparesis raises concerns regarding potential intestinal obstruction and perioperative aspiration risk.”
From Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning (2025) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Both animal and human studies have shown that increased GLP-1 activity reduces intestinal motility [23].”
From Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning (2025) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt-Lindberg, S., Hovingh, G. K., Kahn, S. E., Kushner, R. F., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2307563 · Cited by 3,236
Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
Jastreboff, A. M., Kaplan, L. M., Frías, J. P., Wu, Q., Du, Y., Gurbuz, S., Coskun, T., Haupt, A., Milicevic, Z., & Hartman, M. L. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2301972 · Cited by 1,174
Nauck, M., Frid, A., Hermansen, K., Shah, N. S., Tankova, T., Mitha, I. H., Zdravkovic, M., Düring, M., Matthews, D. R., & for the LEAD-2 Study Group (2009) · Diabetes Care · doi:10.2337/dc08-1355 · Cited by 1,129
Self-citationDrucker, D. J., Buse, J. B., Taylor, K., Kendall, D. M., Trautmann, M., Zhuang, D., & Porter, L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61206-4 · Cited by 1,070
Anti-obesity drug discovery: advances and challenges
Müller, T. D., Blüher, M., Tschöp, M. H., & DiMarchi, R. D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00337-8 · Cited by 1,021
Ghoos, Y. F., Maes, B. D., Geypens, B. J., Mys, G., Hiele, M. I., Rutgeerts, P. J., & Vantrappen, G. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90640-x · Cited by 946
The interdigestive myo‐electric complex of the stomach and small bowel of dogs.
Code, C. F., & Marlett, J. A. (1975) · The Journal of Physiology · doi:10.1113/jphysiol.1975.sp010891 · Cited by 713
Blundell, J., Finlayson, G., Axelsen, M., Flint, A., Gibbons, C., Kvist, T., & Hjerpsted, J. B. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12932 · Cited by 693
Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man
Wettergren, A., Schjoldager, B., Mortensen, P. E., Myhre, J., Christiansen, J., & Holst, J. J. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01316798 · Cited by 670
Filippatos, T. D., Panagiotopoulou, T. V., & Elisaf, M. S. (2014) · The Review of Diabetic Studies · Cited by 560
van Can, J., Sloth, B., Jensen, C. B., Flint, A., Blaak, E. E., & Saris, W. H. M. (2014) · International Journal of Obesity · doi:10.1038/ijo.2013.162 · Cited by 537
Willms, B., Werner, J., Holst, J. J., Orskov, C., Creutzfeldt, W., & Nauck, M. A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550773 · Cited by 502
Self-citationMarx, N., Husain, M., Lehrke, M., Verma, S., & Sattar, N. (2022) · Circulation · doi:10.1161/circulationaha.122.059595 · Cited by 483
Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications
Frier, B. M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.170 · Cited by 481
Sodhi, M., Rezaeianzadeh, R., Kezouh, A., & Etminan, M. (2023) · JAMA · doi:10.1001/jama.2023.19574 · Cited by 471
Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers
Edwards, C. M. B., Stanley, S. A., Davis, R., Brynes, A. E., Frost, G. S., Seal, L. J., Ghatei, M. A., & Bloom, S. R. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.1.e155 · Cited by 464
Regulation of the Gastric Emptying of Glucose
Brener, W., Hendrix, T. R., & McHugh, P. R. (1983) · Gastroenterology · doi:10.1016/s0016-5085(83)80232-7 · Cited by 438
Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms
I˙meryüz, N., Yeğen, B. Ç., Bozkurt, A., Coşkun, T., Villanueva-Peñacarrillo, M. L., & Ulusoy, N. B. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.4.g920 · Cited by 432
Gut Hormones and Appetite Control
Wren, A. M., & Bloom, S. R. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.048 · Cited by 432
Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
Deacon, C. F. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00080 · Cited by 428
Friedrichsen, M., Breitschaft, A., Tadayon, S., Wizert, A., & Skovgaard, D. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14280 · Cited by 427
Rosenstock, J., Frias, J., Jastreboff, A. M., Du, Y., Lou, J., Gurbuz, S., Thomas, M. K., Hartman, M. L., Haupt, A., Milicevic, Z., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01053-x · Cited by 423
Collins, P. J., Horowitz, M., Cook, D. J., Harding, P. E., & Shearman, D. J. (1983) · Gut · doi:10.1136/gut.24.12.1117 · Cited by 412
Self-citationEfficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity
Drucker, D. J. (2024) · Diabetes Care · doi:10.2337/dci24-0003 · Cited by 383
MEASUREMENT OF RATE OF GASTRIC EMPTYING USING CHROMIUM-51
Griffith, G. H., Owen, G. M., Kirkman, S., & Shields, R. (1966) · The Lancet · doi:10.1016/s0140-6736(66)90247-9 · Cited by 358
He, L., Wang, J., Ping, F., Yang, N., Huang, J., Li, Y., Xu, L., Li, W., & Zhang, H. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.0338 · Cited by 356
Gentilcore, D., Chaikomin, R., Jones, K. L., Russo, A., Feinle-Bisset, C., Wishart, J. M., Rayner, C. K., & Horowitz, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2644 · Cited by 351
Self-citationMatikainen, N., Mänttäri, S., Schweizer, A., Ulvestad, A., Mills, D., Dunning, B. E., Foley, J. E., & Taskinen, M.-R. (2006) · Diabetologia · doi:10.1007/s00125-006-0340-2 · Cited by 336
Relationships Between Gastric Emptying, Postprandial Glycemia, and Incretin Hormones
Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2013) · Diabetes Care · doi:10.2337/dc12-1609 · Cited by 335
Self-citationFrias, J. P., Deenadayalan, S., Erichsen, L., Knop, F. K., Lingvay, I., Macura, S., Mathieu, C., Pedersen, S. D., & Davies, M. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01163-7 · Cited by 334
Braden, B., Adams, S., Duan, L.-P., Orth, K.-H., Maul, F.-D., Lembcke, B., Hör, G., & Caspary, W. F. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90202-3 · Cited by 294
Schirra, J., Nicolaus, M., Roggel, R., Katschinski, M., Storr, M., Woerle, H. J., & Göke, B. (2006) · Gut · doi:10.1136/gut.2004.059741 · Cited by 277
Meier, J. J., Gethmann, A., Götze, O., Gallwitz, B., Holst, J. J., Schmidt, W. E., & Nauck, M. A. (2006) · Diabetologia · doi:10.1007/s00125-005-0126-y · Cited by 276
Self-citationGastric emptying and glycaemia in health and diabetes mellitus
Phillips, L. K., Deane, A. M., Jones, K. L., Rayner, C. K., & Horowitz, M. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.202 · Cited by 273
Self-citationKnockdown of GLP-1 Receptors in Vagal Afferents Affects Normal Food Intake and Glycemia
Krieger, J.-P., Arnold, M., Pettersen, K. G., Lossel, P., Langhans, W., & Lee, S. J. (2016) · Diabetes · doi:10.2337/db15-0973 · Cited by 269
Meier, J. J., Nauck, M. A., Pott, A., Heinze, K., Goetze, O., Bulut, K., Schmidt, W. E., Gallwitz, B., & Holst, J. J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.004 · Cited by 266
Self-citationMeier, J. J., Rosenstock, J., Hincelin-Méry, A., Roy-Duval, C., Delfolie, A., Coester, H.-V., Menge, B. A., Forst, T., & Kapitza, C. (2015) · Diabetes Care · doi:10.2337/dc14-1984 · Cited by 262
Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes
Linnebjerg, H., Park, S., Kothare, P. A., Trautmann, M. E., Mace, K., Fineman, M., Wilding, I., Nauck, M., & Horowitz, M. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2008.07.003 · Cited by 261
Self-citationLiu, L., Chen, J., Wang, L., Chen, C., & Chen, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1043789 · Cited by 258
Shaman, A. M., Bain, S. C., Bakris, G. L., Buse, J. B., Idorn, T., Mahaffey, K. W., Mann, J. F. E., Nauck, M. A., Rasmussen, S., Rossing, P., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.055459 · Cited by 255
Self-citationGlucagonlike peptide 1: a newly discovered gastrointestinal hormone
Holst, J. J. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90831-1 · Cited by 252
Glucagon-like peptide analogues for type 2 diabetes mellitus
Shyangdan, D. S., Royle, P., Clar, C., Sharma, P., Waugh, N., & Snaith, A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006423.pub2 · Cited by 246
Hjerpsted, J. B., Flint, A., Brooks, A., Axelsen, M. B., Kvist, T., & Blundell, J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13120 · Cited by 245
Monami, M., Nreu, B., Scatena, A., Cresci, B., Andreozzi, F., Sesti, G., & Mannucci, E. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12926 · Cited by 243
Deane, A. M., Nguyen, N. Q., Stevens, J. E., Fraser, R. J. L., Holloway, R. H., Besanko, L. K., Burgstad, C., Jones, K. L., Chapman, M. J., Rayner, C. K., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1503 · Cited by 238
Self-citationHalawi, H., Khemani, D., Eckert, D., O'Neill, J., Kadouh, H., Grothe, K., Clark, M. M., Burton, D. D., Vella, A., Acosta, A., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30285-6 · Cited by 224
Little, T. J., Pilichiewicz, A. N., Russo, A., Phillips, L., Jones, K. L., Nauck, M. A., Wishart, J., Horowitz, M., & Feinle-Bisset, C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2220 · Cited by 212
Self-citationChoi, M., Camilleri, M., Burton, D., Zinsmeister, A., Forstrom, L., & Nair, K. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70126-4 · Cited by 205
Umapathysivam, M. M., Lee, M. Y., Jones, K. L., Annink, C. E., Cousins, C. E., Trahair, L. G., Rayner, C. K., Chapman, M. J., Nauck, M. A., Horowitz, M., et al. (2014) · Diabetes · doi:10.2337/db13-0893 · Cited by 193
Self-citationEnergy intake and appetite are related to antral area in healthy young and older subjects
Sturm, K., Parker, B., Wishart, J., Feinle-Bisset, C., Jones, K. L., Chapman, I., & Horowitz, M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.3.656 · Cited by 184
Self-citationHveem, K., Jones, K. L., Chatterton, B. E., & Horowitz, M. (1996) · Gut · doi:10.1136/gut.38.6.816 · Cited by 180
Self-citationHorowitz, M., Flint, A., Jones, K. L., Hindsberger, C., Rasmussen, M. F., Kapitza, C., Doran, S., Jax, T., Zdravkovic, M., & Chapman, I. M. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.02.016 · Cited by 179
Self-citationJones, K. L., Horowitz, M., Wishart, M. J., Af, M., Harding, P., & Chatterton, B. E. (1995) · PubMed · Cited by 164
Self-citationHellström, P. M., Näslund, E., Edholm, T., Schmidt, P. T., Kristensen, J., Theodorsson, E., Holst, J. J., & Efendic, S. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.01079.x · Cited by 160
Camilleri, M., & Sanders, K. M. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.10.028 · Cited by 151
Lorenz, M., Pfeiffer, C., Steinsträßer, A., Becker, R. H. A., Rütten, H., Ruus, P., & Horowitz, M. (2013) · Regulatory Peptides · doi:10.1016/j.regpep.2013.04.001 · Cited by 149
Self-citationGibbons, C., Blundell, J., Tetens Hoff, S., Dahl, K., Bauer, R., & Bækdal, T. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14255 · Cited by 149
Schirra, J., Houck, P., Wank, U., Arnold, R., Göke, B., & Katschinski, M. (2000) · Gut · doi:10.1136/gut.46.5.622 · Cited by 145
Adverse drug reactions of GLP-1 agonists: A systematic review of case reports
Shetty, R., Basheer, F. T., Poojari, P. G., Thunga, G., Chandran, V. P., & Acharya, L. D. (2022) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102427 · Cited by 145
Ileal brake: Neuropeptidergic control of intestinal transit
Van Citters, G. W., & Lin, H. C. (2006) · Current Gastroenterology Reports · doi:10.1007/s11894-006-0021-9 · Cited by 144
Urva, S., Coskun, T., Loghin, C., Cui, X., Beebe, E., O'Farrell, L., Briere, D. A., Benson, C., Nauck, M. A., & Haupt, A. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14110 · Cited by 143
Self-citationTolessa, T., Gutniak, M., Holst, J. J., Efendic, S., & Hellström, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci942 · Cited by 139
Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2011) · Experimental Diabetes Research · doi:10.1155/2011/279530 · Cited by 138
Self-citationMaselli, D., Atieh, J., Clark, M. M., Eckert, D., Taylor, A., Carlson, P., Burton, D. D., Busciglio, I., Harmsen, W. S., Vella, A., et al. (2022) · Obesity · doi:10.1002/oby.23481 · Cited by 136
Aune, D., & VATTEN, L. J. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.11.012 · Cited by 127
Gastric inhibitory polypeptide does not inhibit gastric emptying in humans
Meier, J. J., Goetze, O., Anstipp, J., Hagemann, D., Holst, J. J., Schmidt, W. E., Gallwitz, B., & Nauck, M. A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00499.2003 · Cited by 126
Self-citationNakatani, Y., Maeda, M., Matsumura, M., Shimizu, R., Banba, N., Aso, Y., Yasu, T., & Harasawa, H. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.05.009 · Cited by 126
Barrington, P., Chien, J. Y., Showalter, H. D. H., Schneck, K., Cui, S., Tibaldi, F., Ellis, B., & Hardy, T. A. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01364.x · Cited by 120
Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety
Schmidt, P. T., Näslund, E. B., Grybäck, P., Jacobsson, H., Hartmann, B., Holst, J. J., & Hellström, P. M. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00175-7 · Cited by 116
Russo, A., Stevens, J. E., Chen, R., Gentilcore, D., Burnet, R., Horowitz, M., & Jones, K. L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0513 · Cited by 112
Self-citationNagell, C. F., Wettergren, A., Pedersen, J. F., Mortensen, D., & Holst, J. J. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410004424 · Cited by 109
Deane, A. M., Chapman, M. J., Fraser, R. J. L., Summers, M. J., Zaknic, A. V., Storey, J. P., Jones, K. L., Rayner, C. K., & Horowitz, M. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181d9d87a · Cited by 104
Self-citationHalim, M. A., Degerblad, M., Sundbom, M., Karlbom, U., Holst, J. J., Webb, D.-L., & Hellström, P. M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02006 · Cited by 102
The gastrointestinal tract in hunger and satiety signalling
Tack, J., Verbeure, W., Mori, H., Schol, J., Van den Houte, K., Huang, I., Balsiger, L., Broeders, B., Colomier, E., Scarpellini, E., et al. (2021) · United European Gastroenterology Journal · doi:10.1002/ueg2.12097 · Cited by 102
Semaglutide delays 4‐hour gastric emptying in women with polycystic ovary syndrome and obesity
Jensterle, M., Ferjan, S., Ležaič, L., Sočan, A., Goričar, K., Zaletel, K., & Janez, A. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14944 · Cited by 102
Watson, L. E., Xie, C., Wang, X., Li, Z., Phillips, L. K., Sun, Z., Jones, K. L., Horowitz, M., Rayner, C. K., & Wu, T. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02736 · Cited by 99
Self-citationAltered Postprandial Insulin Requirement in IDDM Patients With Gastroparesis
Ishii, M., Nakamura, T., Kasai, F., Onuma, T., Baba, T., & Takebe, K. (1994) · Diabetes Care · doi:10.2337/diacare.17.8.901 · Cited by 98
Vardarli, I., Arndt, E., Deacon, C. F., Holst, J. J., & Nauck, M. A. (2013) · Diabetes · doi:10.2337/db13-0805 · Cited by 98
Self-citationMarathe, C. S., Horowitz, M., Trahair, L. G., Wishart, J. M., Bound, M., Lange, K., Rayner, C. K., & Jones, K. L. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2482 · Cited by 97
Self-citationSilver, H. J., Olson, D., Mayfield, D., Wright, P., Nian, H., Mashayekhi, M., Koethe, J. R., Niswender, K. D., Luther, J. M., & Brown, N. J. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15113 · Cited by 94
Hiramoto, B., McCarty, T. R., Lodhia, N. A., Jenkins, A., Elnaiem, A., Muftah, M., Flanagan, R., & Chan, W. W. (2024) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002820 · Cited by 94
Regulation of nutrient supply: the brain and appetite control
Blundell, J. E., & Halford, J. C. G. (1994) · Proceedings of The Nutrition Society · doi:10.1079/pns19940046 · Cited by 91
Flint, A., Kapitza, C., Hindsberger, C., & Zdravkovic, M. (2011) · Advances in Therapy · doi:10.1007/s12325-010-0110-x · Cited by 91
Schlögl, H., Kabisch, S., Horstmann, A., Lohmann, G., Müller, K., Lepsien, J., Busse-Voigt, F., Kratzsch, J., Pleger, B., Villringer, A., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1925 · Cited by 88
Dahl, K., Brooks, A., Almazedi, F., Hoff, S. T., Boschini, C., & Bækdal, T. A. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14373 · Cited by 87
Jalleh, R. J., Jones, K. L., Rayner, C. K., Marathe, C. S., Wu, T., & Horowitz, M. (2022) · Diabetologia · doi:10.1007/s00125-022-05796-1 · Cited by 87
Self-citationGLP‐1 regulates gastroduodenal motility involving cholinergic pathways
Schirra, J. R. J., Nicolaus, M., Woerle, H. J., Struckmeier, C. A., Katschinski, M., & Göke, B. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01246.x · Cited by 86
Thazhath, S. S., Marathe, C. S., Wu, T., Chang, J., Khoo, J., Kuo, P., Checklin, H. L., Bound, M. J., Rigda, R. S., Crouch, B., et al. (2016) · Diabetes · doi:10.2337/db15-0893 · Cited by 83
Self-citationJones, K. L., Huynh, L. Q., Hatzinikolas, S., Rigda, R. S., Phillips, L. K., Pham, H. T., Marathe, C. S., Wu, T., Malbert, C., Stevens, J. E., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13956 · Cited by 83
Self-citationDifferential effect of PYY1-36 and PYY3-36 on gastric emptying in man
Witte, A.-B., Grybäck, P., Holst, J. J., Hilsted, L., Hellström, P. M., Jacobsson, H., & Schmidt, P. T. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.07.013 · Cited by 80
Horowitz, M., Aroda, V. R., Han, J., Hardy, E., & Rayner, C. K. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12872 · Cited by 79
Self-citationExenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study
Acosta, A., Camilleri, M., Burton, D., O'Neill, J., Eckert, D., Carlson, P., & Zinsmeister, A. R. (2015) · Physiological Reports · doi:10.14814/phy2.12610 · Cited by 78
Action of Insulin Hypoglycemia on Motor and Secretory Functions of the Digestive Tract
Bachrach, W. H. (1953) · Physiological Reviews · doi:10.1152/physrev.1953.33.4.566 · Cited by 67
Incretin‐Based Drugs and Risk of Intestinal Obstruction Among Patients With Type 2 Diabetes
Faillie, J., Yin, H., Yu, O. H. Y., Herrero, A., Altwegg, R., Renoux, C., & Azoulay, L. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2430 · Cited by 67
Jones, K. L., Rigda, R. S., Buttfield, M. D. M., Hatzinikolas, S., Pham, H. T., Marathe, C. S., Wu, T., Lange, K., Trahair, L. G., Rayner, C. K., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13633 · Cited by 66
Self-citationKarakasis, P., Patoulias, D., Pamporis, K., Stachteas, P., Bougioukas, K. I., Klisic, A., Fragakis, N., & Rizzo, M. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155710 · Cited by 66
Quast, D. R., Schenker, N., Menge, B. A., Nauck, M. A., Kapitza, C., & Meier, J. J. (2020) · Diabetes Care · doi:10.2337/dc20-0720 · Cited by 64
Self-citation‘Gastric’ hypoglycaemia – an important concept in diabetes management
Horowitz, M., Jones, K. L., Rayner, C. K., & Read, N. W. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00804.x · Cited by 63
Self-citationLysy, J., Israeli, E., Strauss‐liviatan, N., & Goldin, E. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00800.x · Cited by 63
Rehfeld, J. F., Knop, F. K., Asmar, A., Madsbad, S., Holst, J. J., & Asmar, M. (2018) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2018.1530297 · Cited by 62
Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects
Keller, J., Trautmann, M. E., Haber, H., Tham, L. S., Hunt, T., Mace, K., & Linnebjerg, H. (2012) · Regulatory Peptides · doi:10.1016/j.regpep.2012.08.005 · Cited by 61
Watson, L. E., Phillips, L. K., Wu, T., Bound, M. J., Checklin, H. L., Grivell, J., Jones, K. L., Clifton, P. M., Horowitz, M., & Rayner, C. K. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13604 · Cited by 58
Self-citationGastric Sensory and Motor Functions and Energy Intake in Health and Obesity—Therapeutic Implications
Cifuentes, L., Camilleri, M., & Acosta, A. (2021) · Nutrients · doi:10.3390/nu13041158 · Cited by 57
Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., Diamant, M., Nieuwdorp, M., Groen, A. K., Cahen, D. L., & van Raalte, D. H. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12748 · Cited by 56
Halawi, H., Camilleri, M., Acosta, A., Vazquez-Roque, M., Oduyebo, I., Burton, D., Busciglio, I., & Zinsmeister, A. R. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00190.2017 · Cited by 56
Gether, I. M., Nexøe-Larsen, C., & Knop, F. K. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01008 · Cited by 56
Effect of Glucagon-like Peptide-1 Receptor Antagonism on Appetite and Food Intake in Healthy Men
Steinert, R. E., Schirra, J., Meyer-Gerspach, A. C., Kienle, P., Fischer, H., Schulte, F., Goeke, B., & Beglinger, C. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.083246 · Cited by 52
Effect of Glucagon-Like Peptide-1 Receptor Agonists on Bowel Preparation for Colonoscopy
Yao, R., Gala, K. S., Ghusn, W., Abboud, D. M., Wallace, F. K., & Vargas, E. J. (2024) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002564 · Cited by 52
Nexøe‐Larsen, C. C., Sørensen, P. H., Hausner, H., Agersnap, M., Baekdal, M., Brønden, A., Gustafsson, L. N., Sonne, D. P., Vedtofte, L., Vilsbøll, T., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13420 · Cited by 51
Stevens, J. E., Gilja, O. H., Gentilcore, D., Hausken, T., Horowitz, M., & Jones, K. L. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01630.x · Cited by 50
Self-citationCamilleri, M., Vazquez-Roque, M., Iturrino, J., Boldingh, A., Burton, D., McKinzie, S., Wong, B. S., Rao, A. S., Kenny, E., Månsson, M., et al. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00076.2012 · Cited by 50
Rayner, C. K., Watson, L. E., Phillips, L. K., Lange, K., Bound, M. J., Grivell, J., Wu, T., Jones, K. L., Horowitz, M., Ferrannini, E., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0190 · Cited by 50
Self-citationZhao, Z., Tang, Y., Hu, Y., Zhu, H., Chen, X., & Zhao, B. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-4162 · Cited by 49
Gabe, M. B. N., Breitschaft, A., Knop, F. K., Hansen, M. R., Kirkeby, K., Rathor, N., & Adrian, C. L. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15802 · Cited by 46
Brubaker, P. L. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3078 · Cited by 44
Paracetamol as a Post Prandial Marker for Gastric Emptying, A Food-Drug Interaction on Absorption
Bartholomé, R., Salden, B., Vrolijk, M. F., Troost, F. J., Masclee, A., Bast, A., & Haenen, G. R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136618 · Cited by 43
Basolo, A., Burkholder, J., Osgood, K., Graham, A., Bundrick, S., Frankl, J., Piaggi, P., Thearle, M. S., & Krakoff, J. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.017 · Cited by 43
Flint, A., Kapitza, C., & Zdravkovic, M. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12108 · Cited by 42
Plummer, M. P., Jones, K. L., Annink, C. E., Cousins, C. E., Meier, J. J., Chapman, M. J., Horowitz, M., & Deane, A. M. (2014) · Diabetes Care · doi:10.2337/dc13-1813 · Cited by 40
Self-citationQuast, D. R., Nauck, M. A., Schenker, N., Menge, B. A., Kapitza, C., & Meier, J. J. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14477 · Cited by 39
Self-citationShoemaker, A. H., Silver, H. J., Buchowski, M., Slaughter, J. C., Yanovski, J. A., Elfers, C., Roth, C. L., & Abuzzahab, M. J. (2022) · International Journal of Obesity · doi:10.1038/s41366-021-01043-6 · Cited by 38
Wu, T., Zhang, Y., Shi, Y., Yu, K., Zhao, M., Liu, S., & Zhao, Z. (2022) · Clinical Drug Investigation · doi:10.1007/s40261-022-01202-1 · Cited by 38
Self-citationWang, X., Xie, C., Marathe, C. S., Malbert, C.-H., Horowitz, M., Jones, K. L., Rayner, C. K., Sun, Z., & Wu, T. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107951 · Cited by 37
Self-citationIncretin-based drugs and intestinal obstruction: A pharmacovigilance study
Gudin, B., Ladhari, C., Robin, P., Laroche, M.-L., Babai, S., Hillaire-Buys, D., & Faillie, J.-L. (2020) · Therapies · doi:10.1016/j.therap.2020.02.024 · Cited by 37
Hyperglycemia Potentiates the Slowing of Gastric Emptying Induced by Exogenous GLP-1
Plummer, M. P., Jones, K. L., Cousins, C. E., Trahair, L. G., Meier, J. J., Chapman, M. J., Horowitz, M., & Deane, A. M. (2015) · Diabetes Care · doi:10.2337/dc14-3091 · Cited by 36
Self-citationGastric emptying in health and type 2 diabetes: An evaluation using a 75 g oral glucose drink
Xie, C., Huang, W., Wang, X., Trahair, L. G., Pham, H. T., Marathe, C. S., Young, R. L., Jones, K. L., Horowitz, M., Rayner, C. K., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108610 · Cited by 35
Self-citationUeda, P., Wintzell, V., Melbye, M., Eliasson, B., Söderling, J., Gudbjörnsdottir, S., Hveem, K., Jonasson, C., Svanström, H., Hviid, A., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.08.034 · Cited by 34
Camilleri, M., Carlson, P., & Dilmaghani, S. (2023) · Obesity · doi:10.1002/oby.23941 · Cited by 34
Nguyen, N. Q., Debreceni, T. L., Burgstad, C. M., Neo, M., Bellon, M., Wishart, J. M., Standfield, S., Bartholomeusz, D. L., Rayner, C. K., Wittert, G., et al. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1722-7 · Cited by 33
Self-citationBae, J. H., Choi, H. J., Cho, K. I. K., Kim, L. K., Kwon, J. S., & Cho, Y. M. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0018 · Cited by 33
Hypoglycaemia and gastric emptying
Marathe, C. S., Marathe, J. A., Rayner, C. K., Kar, P., Jones, K. L., & Horowitz, M. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13570 · Cited by 32
Self-citationGlucagon‐like peptide‐1 receptor agonists and the appropriate measurement of gastric emptying
Horowitz, M., Rayner, C. K., Marathe, C. S., Wu, T., & Jones, K. L. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14166 · Cited by 32
Self-citationTremblay, A. J., Lamarche, B., Kelly, I., Charest, A., Lépine, M. ‐., Droit, A., & Couture, P. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12359 · Cited by 31
Pizzimenti, V., Giandalia, A., Cucinotta, D., Russo, G. T., Smits, M., Cutroneo, P. M., & Trifirò, G. (2016) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12373 · Cited by 30
Stevens, J. E., Buttfield, M., Wu, T., Hatzinikolas, S., Pham, H., Lange, K. M., Rayner, C. K., Horowitz, M., & Jones, K. L. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13864 · Cited by 29
Self-citationJalleh, R., Pham, H., Marathe, C. S., Wu, T., Buttfield, M. D., Hatzinikolas, S., Malbert, C. H., Rigda, R. S., Lange, K., Trahair, L. G., et al. (2020) · Nutrients · doi:10.3390/nu12071962 · Cited by 29
Self-citationLerche, S., Soendergaard, L., Rungby, J., Moeller, N., Holst, J. J., Schmitz, O. E., & Brock, B. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03510.x · Cited by 26
Dubé, M., D'Amours, M., & Weisnagel, S. J. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14050 · Cited by 25
Shaddinger, B. C., Young, M. A., Billiard, J., Collins, D. A., Hussaini, A., & Nino, A. (2017) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.940 · Cited by 22
Nahmias, A., Stahel, P., Tian, L., Xiao, C., & Lewis, G. F. (2021) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.121.316311 · Cited by 22
Aigner, L., Becker, B., Gerken, S., Quast, D. R., Meier, J. J., & Nauck, M. A. (2020) · Diabetes Care · doi:10.2337/dc20-1660 · Cited by 21
Self-citationThe Effect of GLP-1 Receptor Agonists on Postprandial Lipaemia
Novodvorský, P., & Haluzík, M. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-00982-3 · Cited by 21
Jalleh, R. J., Wu, T., Jones, K. L., Rayner, C. K., Horowitz, M., & Marathe, C. S. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac330 · Cited by 21
Self-citationTrahair, L. G., Nauck, M. A., Wu, T., Stevens, J. E., Buttfield, M. D., Hatzinikolas, S., Pham, H., Meier, J. J., Rayner, C. K., Horowitz, M., et al. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1784-6185 · Cited by 20
Self-citationvon Gerichten, J., Elnesr, M. H., Prollins, J. E., Mel, I. D., Flanagan, A., Johnston, J. D., Fielding, B. A., & Short, M. (2022) · Lipids · doi:10.1002/lipd.12352 · Cited by 17
Differing effects of liraglutide on gastric emptying in Japanese patients with type 2 diabetes
Nagai, Y., Hashimoto, E., Oikawa, R., Asai, S., Terashima, Y., Nakamura, Y., Sasaki, Y., Tsukiyama, H., Fukuda, H., Ohshige, T., et al. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12247 · Cited by 15
Murthy, T. A., Grivell, J., Hatzinikolas, S., Chapple, L. S., Chapman, M. J., Stevens, J. E., Malbert, C., Rayner, C. K., Horowitz, M., Jones, K. L., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa854 · Cited by 15
Self-citationHompesch, M., Kang, J., Han, O., TRAUTMANN, M. E., SORLI, C. H., Ogbaa, I., Stewart, J. A., & Morrow, L. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002208 · Cited by 15
Antecedent Hypoglycemia Does Not Attenuate the Acceleration of Gastric Emptying by Hypoglycemia
Kar, P., Jones, K. L., Plummer, M. P., Abdelhamid, Y. A., Giersch, E. J., Summers, M. J., Hatzinikolas, S., Heller, S. R., Horowitz, M., & Deane, A. M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00051 · Cited by 14
Self-citationA RARE CASE OF A LARGE BOWEL OBSTRUCTION DUE TO TIRZEPATIDE
GORDON, A., DIXIT, K., Shachi, T., Salonia, J. S., & Seltzer, E. S. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.07.1569 · Cited by 11
Xiang, C., Sun, Y., Luo, Y., Xie, C., Huang, W., Jones, K. L., Horowitz, M., Sun, Z., Rayner, C. K., Ma, J., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15635 · Cited by 11
Self-citationKovoor, J. G., Rayner, C. K., Wu, T., Jalleh, R. J., Maddern, G. J., Horowitz, M., & Jones, K. L. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108793 · Cited by 11
Self-citationValenzuela‐Vallejo, L., Chrysafi, P., & Mantzoros, C. S. (2022) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101369 · Cited by 9
Sun, Y., Luo, Y., Xiang, C., Xie, C. H., Huang, W., Sun, Z., Jones, K. L., Horowitz, M., Rayner, C. K., Ma, J., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15626 · Cited by 9
Self-citationBennett, D., Davé, S., Sakaguchi, M., Chang, C., & Dolin, P. (2016) · Diabetology International · doi:10.1007/s13340-016-0261-3 · Cited by 8
Gandhi, A., Khanam, V., Peterson, D., Patel, F., & Kulairi, Z. I. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa046.609 · Cited by 7
Horowitz, M., Rayner, C. K., Marathe, C. S., Wu, T., Umapathysivam, M. M., & Jones, K. L. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14473 · Cited by 7
Self-citationMather, K. J., Coşkun, T., Pratt, E. J., Miličević, Z., Weerakkody, G. J., Thomas, M. K., Haupt, A., & Ruotolo, G. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15365 · Cited by 7
Xiang, C., Sun, Y., Luo, Y., Xie, C., Huang, W., Sun, Z., Jones, K. L., Horowitz, M., Rayner, C. K., Ma, J., et al. (2024) · Nutrition and Diabetes · doi:10.1038/s41387-024-00264-8 · Cited by 7
Self-citation
Research works printed but not linked: 1
- Jalleh, 2024, [Abstract] short-acting glucagon-like peptide-1 receptor agonist therapy delays gastric emptying during insulin-induced hypoglycaemia as well as euglycaemia in type 2 diabetes, Diabetologia, 67, S45
Cited by
Glucagon-like peptide-1 receptor agonists and muscle mass effects
Ceasovschih, A., Asaftei, A., Lupo, M. G., Kotlyarov, S., Bartušková, H., Balta, A., Sorodoc, V., Sorodoc, L., & Banach, M. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107927 · Cited by 64
Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning
Kim, J. A., & Yoo, H. J. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0242 · Cited by 71
“Both animal and human studies have shown that increased GLP-1 activity reduces intestinal motility [23].”
Muzurović, E. M., Katsiki, N., Volčanšek, Š., Plescia, F., Rizzo, M., & Mantzoros, C. S. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156494 · Cited by 25
GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
Migliorisi, G., Gabbiadini, R., Buono, A. D., Ferraris, M., Privitera, G., Petronio, L., Bertoli, P., Bezzio, C., & Armuzzi, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1610368 · Cited by 26
Saha, B., Kamalumpundi, V., & Codipilly, D. C. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2025.09.017 · Cited by 26
Metadata
- Authors
- Jalleh, R. J., Marathe, C. S., Rayner, C. K., Jones, K. L., Umapathysivam, M. M., Wu, T., Quast, D. R., Plummer, M. P., Nauck, M. A., & Horowitz, M.
- Affiliations
- Royal Adelaide Hospital (AU)
- The University of Adelaide (AU)
- St. Josef-Hospital (DE)
- Universitätsmedizin Greifswald (DE)
- Corresponding author
- Horowitz, Michael
- ORCID
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2024-11-21
- Volume
- 166
- Issue
- 1
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- PMC
- PMC11630531
- OpenAlex
- W4404599306
- Semantic Scholar
- 3cc381b931212977ce9dd942992d266b1a137aea
- Cited by
- 61
- References
- 161
- Citations by year
- 2026: 42 · 2025: 19
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UniSA Research Outputs Repository (University of South Australia) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- GLP-1 receptor agonists, tirzepatide, incretin-based therapy, gastric emptying, gallbladder motility, biliary function, small intestine motility, type 2 diabetes, obesity, postprandial triglycerides, hypoglycemia, biliary tract diseases, gastrointestinal adverse effects
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor Agonists, Animals, Biliary Tract, Diabetes Mellitus, Type 2, Gastric Emptying, Gastrointestinal Motility, Humans, Hypoglycemic Agents, Glucagon-Like Peptide 1, Incretins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.